Floatz logo

Therapeutic Asset Ratings

329 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
cs060380
Obesity Disorder
Cascade Pharmaceuticals, IncP2CC (46)
Disulfiram
Obesity Disorder
University of OklahomaP2CC (46)
D-thioctic acid
Obesity Disorder
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)P2CC (46)
Epigallocatechin-3-Gallate
Obesity Disorder
Purdue UniversityP2CC (46)
GLYCERIN,ANHYDROUS
Obesity Disorder
Rutgers, The State University of New JerseyP2CC (46)
ht-6184
Obesity Disorder
Halia Therapeutics, Inc.P2CC (46)
HUMAN MONOCLONAL ANTIBODY TO GDF8 (MYOSTATIN)
Obesity Disorder
Regeneron PharmaceuticalsP2CC (46)
Kbp-336
Obesity Disorder
KeyBioscience AGP2CC (46)
L-Citrulline
Obesity
University of Colorado, DenverP2CC (46)
L-Ctirulline
Obesity Disorder
University of Colorado, DenverP2CC (46)
ly6249492
Obesity Disorder
Eli Lilly and CompanyP2CC (46)
Marijuana
Obesity
Joshua A. Lile, Ph.D.P2CC (46)
mbl949
Obesity Disorder
Novartis PharmaceuticalsP2CC (46)
mkp10241
Obesity Disorder
Mankind Pharma LimitedP2CC (46)
Multiple Vitamins Injection
Obesity Disorder
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant PauP2CC (46)
Nabilone
Obesity Disorder
Centre for Addiction and Mental HealthP2CC (46)
Nimacimab
Obesity Disorder
Skye Bioscience, Inc.P2CC (46)
nt-0796
Obesity Disorder
NodThera LimitedP2CC (46)
Pegargiminase
Obesity Disorder
Washington University School of MedicineP2CC (46)
Ribupatide
Obesity Disorder
KaileraP2CC (46)
(S)-(-)-pindolol benzoate
Obesity Disorder
Actimed Therapeutics LtdP2CC (46)
Sucralose
Obesity Disorder
Virginia Polytechnic Institute and State UniversityP2CC (46)
Taldefgrobep Alfa
Obesity Disorder
Biohaven Therapeutics Ltd.P2CC (46)
Vericiguat
Obesity Disorder
University of Alabama at BirminghamP2CC (46)
DEUTERATED WATER
Obesity Disorder
Columbia UniversityP1/2CC (45)
Showing 176 to 200 of 329 assets
PreviousPage 8 of 14Next